At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 28 enrolled
Drug / intervention
photodynamic therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma
Shahid Beheshti University of Medical Sciences·interventional·Posted Sep 28, 2009·Updated Dec 22, 2009
In Brief
A Phase 1 clinical trial evaluating photodynamic therapy for Basal Cell Carcinoma. Completed, enrolled 28 participants.
Detailed Summary
The purpose of this study is to evaluate the efficacy of pdt in treatment of bcc and factors that affect response rate.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBasal Cell Carcinoma
Countries--
Collaborators--
Timeline
Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
Primary CompletionJul 2008
Study CompletionMar 2009
First PostedSep 2009
TodayJul 2026
First PostedSep 28, 2009
Enrollment StartJan 1, 2008
Primary CompletionJul 1, 2008
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.8 years ago
Interventions
photodynamic therapyradiation
treatment of bcc with 5\_ALA cream 20% topical administration once monthly+ photodynamic therapy (red light) 120 j/cm2 once monthly